Laurus Labs Share Price Target 2026 to 2050

Laurus Labs Ltd (NSE: LAURUSLABS) is a well-known pharmaceutical company in India focused on generic drugs, active pharmaceutical ingredients, and contract manufacturing services. The company plays a key role in producing affordable healthcare products and life-saving medicines for the global market. It operates in areas such as antiviral drugs, oncology drugs, and biotech research. Laurus Labs is popular among investors looking for pharma stocks in India, fast-growing pharmaceutical companies, and long-term healthcare investment opportunities. With robust research, global exports, and quality manufacturing, the company supports the continued growth of the pharmaceutical and healthcare sectors.

Laurus Labs Fundamental Analysis

Metric	Value
Market Cap	₹1,08,062 Cr
ROE	16.77%
P/E Ratio (TTM)	99.11
EPS (TTM)	20.18
P/B Ratio	20.39
Dividend Yield	0.10%
Industry P/E	37.59
Book Value	98.09
Debt to Equity	0.48
Face Value	2

Laurus Labs Share Price Target 2026

Laurus Labs share price target for 2026 is expected to range from ₹1000 to ₹3000. Here are three key factors that could affect the company’s share price in 2026:

• Active Pharmaceutical Ingredients Demand: Laurus Labs is a giant in making Active Pharmaceutical Ingredients, which are the main medical ingredients in medicines. When global demand for HIV, cancer, and heart care ingredients grows, the company sells more volume, boosting total profits and share price.
• Synthesis Business Expansion: The company makes custom chemicals for big foreign drug companies through its contract development division. Because these custom products carry high profit margins, expanding this business segment drives up net earnings, making the company stock much more valuable to market investors.
• Finished Dosage Formulations: Instead of selling only raw drug ingredients, Laurus Labs produces finished medicine tablets. Selling finished doses directly to big global markets brings in higher revenues, protects overall profit margins, and strengthens long-term shareholder trust in company financial growth.

Laurus Labs Share Price Target 2027

Laurus Labs share price target for 2027 is expected to range from ₹2000 to ₹4000. Here are three key factors that could affect the company’s share price in 2027:

• Continuous Research Investments: Spending a substantial part of annual revenues on research facilities helps scientists create complex new drug molecules. Launching advanced high-value medicines gives the business a strong market advantage over competitors, supporting steady share growth across major stock market exchanges.
• Strategic Bio-Division Growth: Expanding its biotechnology business through Laurus Bio creates new revenue streams in animal-free proteins and enzymes. Entering green biotech sectors expands market opportunities beyond traditional chemistry, attracting modern ESG-focused investment funds to purchase and hold the stock.
• Strong Backward Integration: Manufacturing fundamental raw chemical intermediates inside its own factories reduces reliance on outside suppliers. Self-sufficiency lowers manufacturing expenses, protects factory operations during global supply breakdowns, and keeps operational profit margins stable during difficult business cycles.

Laurus Labs Share Price Target 2030

Laurus Labs share price target for 2030 is expected to range from ₹9000 to ₹12000. Here are three key factors that could affect the company’s share price in 2030:

• Capacity Expansion at Factories: Building new state-of-the-art production plants allows Laurus Labs to complete larger global supply orders faster. Increasing total factory capacity creates strong long-term sales potential, reassuring investors that future quarterly earnings can continuously expand over coming financial years.
• Diversifying Away From ARV: Historically, the business relied heavily on selling anti-retroviral HIV ingredients. Successfully expanding into oncology, cardio, and diabetes treatments balances revenue streams, protecting company performance if demand for old HIV drug formulations drops in developing nations.
• Export Sales Growth: Exporting pharmaceutical goods to regulated markets across North America, Europe, and Asia generates valuable foreign currency revenue. Expanding global distribution networks protects total company earnings when domestic Indian medicine sales face temporary slowdowns or local price caps.

Laurus Labs Share Price Target 2040

Laurus Labs share price target for 2040 is expected to range from ₹22000 to ₹27000. Here are three risks & challenges that could affect the company’s share price in 2040:

• Strict Regulatory Plant Inspections: Global health agencies like the US FDA conduct frequent, strict factory audits on production plants. If inspectors issue official warning letters or import alerts due to manufacturing issues, factory exports get blocked, causing sharp sales drops and share price falls.
• Raw Material Volatility: Relying on imported starting chemicals exposes factory production to sudden cost increases. If raw material prices spike or global supply chains stall, Laurus Labs struggles to pass costs to buyers, directly squeezing operating profit margins.
• Pricing Pressure in Generics: Generic drug markets in Western nations face intense price wars among competing suppliers. If global buyers demand steep price discounts on generic medicine tablets, Laurus Labs earns less income per unit, hurting overall company profitability metrics.

Laurus Labs Share Price Target 2050

Laurus Labs share price target for 2050 is expected to range from ₹53000 to ₹59000. Here are three risks & challenges that could affect the company’s share price in 2050:

• Heavy Foreign Exchange Risk: Exporting goods across international markets means earnings depend heavily on volatile currency exchange rates. Unfavorable shifts between the Indian Rupee, US Dollar, and Euro can unexpectedly shrink final reported profits when converting international income back home.
• Slower CDMO Order Execution: Contract development relies on foreign drug developers hitting clinical trial milestones on schedule. If customer clinical trials delay or drug projects get canceled, custom manufacturing orders freeze suddenly, leaving expensive specialized plant capacity underutilized for long periods.
• High Factory Capital Costs: Building advanced chemical factories requires heavy ongoing capital expenditure and ongoing borrowing. If expanded facilities take longer than expected to generate steady commercial orders, high interest payments and factory depreciation expenses reduce overall corporate net margins.

Laurus Labs Share Price Target 2026 to 2050

Year	Target Price (₹)
2026	1000 to 3000
2027	2000 to 4000
2028	4000 to 6000
2029	6000 to 9000
2030	9000 to 12000
2040	22000 to 27000
2050	53000 to 59000

Also Read: Happiest Minds Share Price Target

Laurus Labs Shareholding Pattern

Shareholding Pattern (June 2026)

Category	Holding
Public	30.78%
FII	28.00%
Promoters	27.47%
DII	13.74%

Laurus Labs Key Competitors

Divi’s Laboratories, Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla, Sun Pharmaceutical Industries, Lupin, Torrent Pharmaceuticals, Biocon, Alkem Laboratories, and Zydus Lifesciences.